Epidemic

Looking at 10 years of data, experts recommend improvements to the flu vaccine

Q&A with Arnold Monto

According to a new study published in the journal Clinical Infectious Diseases, while there have been major advances over the last decade in an effort to improve the effectiveness of seasonal influenza vaccine, innovative approaches are needed to significantly improve vaccine effectiveness. Study author Arnold Monto, professor of Epidemiology at the University of Michigan School of Public Health, discusses the findings.

Arnold Monto Receives Lifetime Achievement Award for Illustrious Contributions to Respiratory Virus Disease Research

For outstanding contributions to respiratory virus disease research over the course of his career, Dr. Arnold Monto, the Thomas Francis, Jr. Collegiate Professor of Public Health, has received the Lifetime Achievement Award from the International Society for Influenza and other Respiratory Virus Diseases (ISIRV).

What to know about the new COVID-19 booster shots

Aubree Gordon quoted in the New York Times

A new COVID-19 booster shot for the Omricon variant will be made available. Aubree Gordon, associate professor of Epidemiology at the University of Michigan School of Public Health, describes the number of weeks it takes for anti-bodies from the booster shot to start working.

Long COVID: Women, Hispanics and lower-income Michiganders hit hardest

New MI CReSS Report

Long COVID was more prevalent among women, Hispanics and those with lower incomes, according to the most recent Michigan COVID-19 Recovery Surveillance Study report.

Increasing public health measures could have helped prevent thousands of COVID-19 deaths in India

New research from Michigan Public Health

Strengthening public health measures at the sign of resurgence of SARS-CoV-2 in India in early 2021 would have helped control transmission in the country and reduced mortality by at least 40% during the second wave even without harsh lockdowns, according to a new University of Michigan study.

Minorities saw steeper drop in access to opioid use disorder meds during pandemic

New research from Thuy Nguyen

Relative to white patients, racial and ethnic groups saw a sharper decline in access to medicines to treat opioid use disorder during the early stages of the COVID-19 pandemic—intensifying pre-pandemic disparities, says a University of Michigan researcher.